5Y25

EGFR kinase domain mutant (T790M/L858R) with covalent ligand NS-062

Summary for 5Y25

• Entry DOI: 10.2210/pdb5y25/pdb
• Descriptor: Epidermal growth factor receptor, (2R)-N-[4-[(3-chloranyl-4-fluoranyl-phenyl)amino]-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]-1-(2-fluoranylethanoyl)pyrrolidine-2-carboxamide (2 entities in total)
• Functional Keywords: inhibitor, complex, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• Biological source: Homo sapiens (Human)
• Total number of polymer chains: 1
• Total formula weight: 38741.19

Authors

Shiroishi, M.,Abe, Y.,Caaveiro, J.M.M.,Sakamoto, S.,Morimoto, S.,Fuchida, H.,Shindo, N.,Ojida, A. (deposition date: 2017-07-24, release date: 2018-07-25, Last modification date: 2023-11-22)

• Primary citation: Shindo, N.,Fuchida, H.,Sato, M.,Watari, K.,Shibata, T.,Kuwata, K.,Miura, C.,Okamoto, K.,Hatsuyama, Y.,Tokunaga, K.,Sakamoto, S.,Morimoto, S.,Abe, Y.,Shiroishi, M.,Caaveiro, J.M.M.,Ueda, T.,Tamura, T.,Matsunaga, N.,Nakao, T.,Koyanagi, S.,Ohdo, S.,Yamaguchi, Y.,Hamachi, I.,Ono, M.,Ojida, A.; Selective and reversible modification of kinase cysteines with chlorofluoroacetamides.; Nat.Chem.Biol., 15:250-258, 2019; PubMed: 30643284; DOI: 10.1038/s41589-018-0204-3

Experimental method

X-RAY DIFFRACTION (3.102 Å)